Madrigal Pharmaceuticals Stock Options
| MDGL Stock | USD 293.64 20.85 7.64% |
Madrigal Pharmaceuticals' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 0.66 with a put-to-call open interest ratio of 0.75 over 77 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on April 17th 2025. The total put volume is at 3.0, with calls trading at the volume of 184. This yields a 0.02 put-to-call volume ratio.
Open Interest Against April 17th 2025 Option Contracts
2025-04-17
The chart above shows Madrigal Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Madrigal Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Madrigal Pharmaceuticals' option, there is no secondary market available for investors to trade.
Madrigal Pharmaceuticals Maximum Pain Price Across 2025-04-17 Option Contracts
Madrigal Pharmaceuticals' max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Madrigal Pharmaceuticals
Analyzing Madrigal Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Madrigal Pharmaceuticals regardless of its overall volatility. This is especially true when Madrigal Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Madrigal Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Madrigal Pharmaceuticals' stock while costing only a fraction of its price.
Madrigal Pharmaceuticals In The Money Call Balance
When Madrigal Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Madrigal Pharmaceuticals stock is said to be in the money. When it comes to buying Madrigal Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Madrigal Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Madrigal Current Options Market Mood
Madrigal Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Madrigal Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Madrigal Pharmaceuticals' options investors are not very successful. Madrigal Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Madrigal contract
Base on the Rule 16, the options market is currently suggesting that Madrigal Pharmaceuticals will have an average daily up or down price movement of about 0.0413% per day over the life of the 2025-04-17 option contract. With Madrigal Pharmaceuticals trading at USD 293.64, that is roughly USD 0.12. If you think that the market is fully incorporating Madrigal Pharmaceuticals' daily price movement you should consider buying Madrigal Pharmaceuticals options at the current volatility level of 0.66%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Madrigal |
Purchasing Madrigal Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Madrigal calls. Remember, the seller must deliver Madrigal Pharmaceuticals stock to the call owner when a call is exercised.
Madrigal Pharmaceuticals Option Chain
When Madrigal Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Madrigal Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Madrigal Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Madrigal. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Madrigal. It also shows strike prices and maturity days for a Madrigal Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | MDGL250417C00200000 | 4 | 200.0 | 94.2 - 103.8 | 101.35 | In |
Call | MDGL250417C00210000 | 4 | 210.0 | 85.7 - 95.0 | 119.2 | In |
Call | MDGL250417C00220000 | 17 | 220.0 | 77.4 - 87.0 | 127.3 | In |
Call | MDGL250417C00230000 | 11 | 230.0 | 69.5 - 79.0 | 67.1 | In |
Call | MDGL250417C00240000 | 24 | 240.0 | 62.1 - 72.0 | 87.4 | In |
Call | MDGL250417C00250000 | 13 | 250.0 | 55.0 - 64.8 | 44.2 | In |
Call | MDGL250417C00260000 | 45 | 260.0 | 48.4 - 58.0 | 73.3 | In |
Call | MDGL250417C00270000 | 20 | 270.0 | 42.4 - 52.0 | 50.0 | In |
Call | MDGL250417C00280000 | 45 | 280.0 | 37.2 - 46.0 | 41.0 | In |
Call | MDGL250417C00290000 | 53 | 290.0 | 31.9 - 41.0 | 24.65 | In |
Call | MDGL250417C00300000 | 220 | 300.0 | 27.8 - 36.7 | 36.0 | Out |
Call | MDGL250417C00310000 | 8 | 310.0 | 23.7 - 32.7 | 45.9 | Out |
Call | MDGL250417C00320000 | 80 | 320.0 | 19.6 - 28.8 | 14.4 | Out |
Call | MDGL250417C00330000 | 22 | 330.0 | 16.4 - 25.9 | 22.14 | Out |
Call | MDGL250417C00340000 | 54 | 340.0 | 14.0 - 23.2 | 20.7 | Out |
Call | MDGL250417C00350000 | 67 | 350.0 | 11.4 - 20.4 | 16.7 | Out |
Call | MDGL250417C00360000 | 6 | 360.0 | 9.7 - 18.9 | 15.35 | Out |
Call | MDGL250417C00370000 | 357 | 370.0 | 8.0 - 16.9 | 10.69 | Out |
Call | MDGL250417C00380000 | 6 | 380.0 | 6.3 - 15.0 | 16.0 | Out |
Call | MDGL250417C00390000 | 55 | 390.0 | 4.6 - 13.9 | 8.0 | Out |
Call | MDGL250417C00400000 | 9 | 400.0 | 3.3 - 12.0 | 8.0 | Out |
Call | MDGL250417C00410000 | 16 | 410.0 | 2.45 - 12.0 | 0.25 | Out |
Call | MDGL250417C00420000 | 3 | 420.0 | 2.25 - 10.1 | 11.6 | Out |
Call | MDGL250417C00430000 | 65 | 430.0 | 1.45 - 9.5 | 10.7 | Out |
Call | MDGL250417C00440000 | 0 | 440.0 | 0.5 - 9.1 | 0.5 | |
Call | MDGL250417C00450000 | 2 | 450.0 | 0.2 - 9.0 | 2.05 | Out |
Call | MDGL250417C00460000 | 14 | 460.0 | 0.05 - 7.6 | 1.8 | Out |
Call | MDGL250417C00470000 | 0 | 470.0 | 0.0 - 7.5 | 3.5 | |
Call | MDGL250417C00480000 | 0 | 480.0 | 0.0 - 6.5 | 6.5 | |
Call | MDGL250417C00490000 | 0 | 490.0 | 0.0 - 6.9 | 6.9 | |
Call | MDGL250417C00500000 | 2 | 500.0 | 0.0 - 6.9 | 6.7 | Out |
Call | MDGL250417C00510000 | 2 | 510.0 | 0.0 - 5.9 | 3.6 | Out |
Call | MDGL250417C00520000 | 0 | 520.0 | 0.0 - 5.7 | 5.7 | |
Call | MDGL250417C00530000 | 0 | 530.0 | 0.0 - 5.6 | 5.6 | |
Put | MDGL250417P00120000 | 1 | 120.0 | 0.0 - 4.2 | 0.55 | Out |
Put | MDGL250417P00125000 | 3 | 125.0 | 0.0 - 4.2 | 0.55 | Out |
Put | MDGL250417P00130000 | 5 | 130.0 | 0.0 - 4.2 | 0.8 | Out |
Put | MDGL250417P00140000 | 1 | 140.0 | 0.0 - 4.3 | 0.6 | Out |
Put | MDGL250417P00145000 | 2 | 145.0 | 0.0 - 4.4 | 0.7 | Out |
Put | MDGL250417P00150000 | 1 | 150.0 | 0.0 - 4.4 | 0.85 | Out |
Put | MDGL250417P00155000 | 2 | 155.0 | 0.0 - 4.4 | 1.0 | Out |
Put | MDGL250417P00160000 | 3 | 160.0 | 0.0 - 4.6 | 1.05 | Out |
Put | MDGL250417P00165000 | 2 | 165.0 | 0.0 - 5.5 | 0.6 | Out |
Put | MDGL250417P00170000 | 2 | 170.0 | 0.0 - 4.8 | 1.4 | Out |
Put | MDGL250417P00175000 | 3 | 175.0 | 0.0 - 6.0 | 1.37 | Out |
Put | MDGL250417P00180000 | 1 | 180.0 | 0.0 - 6.4 | 11.2 | Out |
Put | MDGL250417P00185000 | 1 | 185.0 | 0.0 - 6.8 | 3.3 | Out |
Put | MDGL250417P00195000 | 33 | 195.0 | 0.0 - 6.8 | 3.2 | Out |
Put | MDGL250417P00200000 | 5 | 200.0 | 0.05 - 6.5 | 2.3 | Out |
Put | MDGL250417P00210000 | 1 | 210.0 | 0.15 - 8.9 | 8.19 | Out |
Put | MDGL250417P00220000 | 75 | 220.0 | 1.25 - 10.0 | 7.5 | Out |
Put | MDGL250417P00230000 | 25 | 230.0 | 4.3 - 12.9 | 15.01 | Out |
Put | MDGL250417P00240000 | 7 | 240.0 | 6.1 - 15.0 | 14.9 | Out |
Put | MDGL250417P00250000 | 93 | 250.0 | 9.2 - 18.0 | 17.5 | Out |
Put | MDGL250417P00260000 | 54 | 260.0 | 12.3 - 21.6 | 17.2 | Out |
Put | MDGL250417P00270000 | 46 | 270.0 | 16.5 - 25.9 | 21.32 | Out |
Put | MDGL250417P00280000 | 10 | 280.0 | 21.3 - 29.9 | 22.0 | Out |
Put | MDGL250417P00300000 | 289 | 300.0 | 31.0 - 40.0 | 44.75 | In |
Put | MDGL250417P00310000 | 37 | 310.0 | 36.9 - 46.0 | 40.9 | In |
Put | MDGL250417P00320000 | 6 | 320.0 | 43.2 - 52.6 | 37.3 | In |
Put | MDGL250417P00330000 | 192 | 330.0 | 50.0 - 59.5 | 33.74 | In |
Put | MDGL250417P00340000 | 1 | 340.0 | 57.3 - 66.7 | 133.0 | In |
Put | MDGL250417P00350000 | 15 | 350.0 | 65.0 - 74.3 | 85.9 | In |
Put | MDGL250417P00360000 | 1 | 360.0 | 73.0 - 82.2 | 50.7 | In |
Put | MDGL250417P00370000 | 1 | 370.0 | 81.0 - 90.5 | 160.7 | In |
Put | MDGL250417P00380000 | 1 | 380.0 | 89.6 - 98.9 | 170.2 | In |
Put | MDGL250417P00400000 | 1 | 400.0 | 107.0 - 116.9 | 86.04 | In |
Put | MDGL250417P00440000 | 0 | 440.0 | 144.0 - 153.8 | 118.37 | In |
Put | MDGL250417P00450000 | 0 | 450.0 | 153.0 - 162.9 | 153.0 | In |
Put | MDGL250417P00460000 | 0 | 460.0 | 163.0 - 172.9 | 163.0 | In |
Put | MDGL250417P00470000 | 0 | 470.0 | 172.1 - 182.0 | 172.1 | In |
Put | MDGL250417P00480000 | 0 | 480.0 | 182.1 - 192.0 | 182.1 | In |
Put | MDGL250417P00490000 | 0 | 490.0 | 192.0 - 201.9 | 192.0 | In |
Put | MDGL250417P00500000 | 0 | 500.0 | 202.0 - 211.9 | 202.0 | In |
Put | MDGL250417P00510000 | 0 | 510.0 | 212.0 - 221.8 | 212.0 | In |
Put | MDGL250417P00520000 | 0 | 520.0 | 222.0 - 231.8 | 222.0 | In |
Put | MDGL250417P00530000 | 0 | 530.0 | 231.1 - 241.0 | 231.1 | In |
Madrigal Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Madrigal Total Stockholder Equity
Total Stockholder Equity |
|
Madrigal Pharmaceuticals Corporate Management
| Justin Drinkwine | Senior VP | Profile | |
| Thomas Hare | Senior Management | Profile | |
| Remy Sukhija | VP Officer | Profile | |
| PharmD MBA | Senior Affairs | Profile | |
| Mark Underwood | Senior Operations | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.